The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 14, 2010

Filed:

May. 14, 2007
Applicants:

Edward R. Bacon, Audubon, PA (US);

Thomas Bailey, Phoenixville, PA (US);

Nadine C. Becknell, Coatesville, PA (US);

Diane E. Gingrich, Downingtown, PA (US);

Greg Hostetler, Newark, DE (US);

Robert L. Hudkins, Chester Springs, PA (US);

Keith S. Learn, Perkiomenville, PA (US);

Jason C. Wagner, Coatesville, PA (US);

Inventors:

Edward R. Bacon, Audubon, PA (US);

Thomas Bailey, Phoenixville, PA (US);

Nadine C. Becknell, Coatesville, PA (US);

Diane E. Gingrich, Downingtown, PA (US);

Greg Hostetler, Newark, DE (US);

Robert L. Hudkins, Chester Springs, PA (US);

Keith S. Learn, Perkiomenville, PA (US);

Jason C. Wagner, Coatesville, PA (US);

Assignee:

Cephalon, Inc., Frazer, PA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/541 (2006.01); A61K 31/5355 (2006.01); A61K 31/497 (2006.01); A61K 31/519 (2006.01); C07D 279/12 (2006.01); C07D 417/14 (2006.01); C07D 413/14 (2006.01); C07D 519/00 (2006.01); C07D 487/04 (2006.01); A61K 31/517 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention is related to chemical compositions, processes for the preparation thereof and uses of the composition. Particularly, the present invention relates to compositions that include substituted heterobicyclic pyrimidines of Formula (I): wherein R, R, R, R, R, X, W, and ring A are as defined herein; pharmaceutical compositions of substituted heterobicyclic pyrimidines of Formula (I); and their use in the treatment of chronic neurodegenerative diseases, neurotraumatic diseases, depression and/or diabetes. More particularly, the present invention relates to substituted pyrazolopyrimidines of Formula (I).


Find Patent Forward Citations

Loading…